(Press-News.org) Eric Gaier, MD, PhD, and Dean Eliott, MD, of the Department of Ophthalmology at Mass Eye and Ear, a member of the Mass General Brigham healthcare system, are co-authors of a paper published in Ophthalmology Retina, “Substance Use Disorder Interventions and Ophthalmic Outcomes for Injection Drug Use-Associated Endogenous Endophthalmitis.”
Q: What challenges or unmet needs make this study important?
People who use injection drugs are at a higher risk for eye infections, particularly endogenous endophthalmitis—a medical emergency caused by bacteria or fungi entering the bloodstream to reach the inside of the eye. These individuals may present to eye clinics or emergency rooms with severe, vision-threatening disease. However, the underlying substance use disorder that led to their infection is often not addressed in a systematic way.
These encounters represent a critical—and often missed—opportunity to connect patients with evidence-based, life-saving addiction treatments. As ophthalmologists, we are often the first specialists involved in caring for these patients, placing vision care at a unique intersection between acute medical illness and long-term health outcomes.
Q: What central question(s) were you investigating?
First, we wanted to determine whether involving addiction consult services in our care of these patients actually changed their access to medications for substance use disorder (specifically, opioid use disorder).
Second, we sought to understand what clinical or substance-related factors are associated with worse visual outcomes, particularly in the current era of increased fentanyl use.
Q: What methods or approach did you use?
We reviewed the clinical course of patients treated for injection drug use–associated endogenous endophthalmitis at Mass General Brigham over a six-year period. We examined both ophthalmic outcomes—such as vision and complications—and addiction-related care, including whether patients were seen by an addiction consult service and whether medications for opioid use disorder were initiated.
Q: What did you find?
We found that medications for opioid use disorder were only initiated when the addiction consult service was involved, and never when it wasn’t. In other words, without formal addiction consultation, eligible patients simply did not receive these life-saving treatments for their substance use.
From an ophthalmic standpoint, most patients experienced improvements in vision, but those who reported fentanyl use had dramatically worse outcomes, with more than five-fold higher odds of severe vision loss. These findings highlight fentanyl as a particularly dangerous factor not only for overdose risk, but also for irreversible visual disability.
Q: What are the real-world implications, particularly for patients?
This study reinforces that eye doctors can offer much more to patients than vision care alone. For patients with injection drug use–related infections, an ophthalmology visit may be one of the few times they engage with the healthcare system. Ensuring that addiction consult services are involved through these encounters can directly impact these individuals’ survival, not just their sight.
For patients and families, the message is clear: addressing substance use disorder alongside acute medical problems is essential to preventing both vision loss and life-threatening complications.
Q: What part of this research feels most meaningful personally?
What feels most meaningful is demonstrating that ophthalmologists can play an active role in connecting patients to life-saving addiction care. Vision loss may be what brings a patient to the hospital, but addressing the underlying condition, substance use disorder, has the potential to change the trajectory of or save someone’s life.
Mass Eye and Ear is a member of a large health system with addiction medicine and infectious disease services readily available. This ecosystem enables our ophthalmologists to direct patients with challenging, life-threatening or multi-system disease to multidisciplinary care that can be invaluable.
Authorship: In addition to Gaier and Eliott, Mass General Brigham authors include George N. Papaliodis and Eugene Lambert.
Paper cited: Sokol J.T., et al. “Substance Use Disorder Interventions and Ophthalmic Outcomes for Injection Drug Use-Associated Endogenous Endophthalmitis.” Ophthalmology Retina. DOI: 10.1016/j.oret.2026.01.004
Disclosures: None.
About Mass General Brigham
Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org.
END
Bridging eye disease care with addiction services
2026-02-10
ELSE PRESS RELEASES FROM THIS DATE:
Study finds declining perception of safety of COVID-19, flu, and MMR vaccines
2026-02-10
In a winter marked by flu outbreaks, the persistence of Covid-19, and surges of measles cases across the United States, an Annenberg survey finds that a sizable majority of Americans think the three vaccines that combat these potentially deadly illnesses are safe to take, although perceptions of the safety of all three vaccines showed a statistically significant drop over the past three years.
Flu levels are rising across the United States, according to the Centers for Disease Control and Prevention (CDC), with visits to emergency departments increasing for children over five. In 2025, measles cases hit their highest level in the United States since 1991, ...
The genetics of anxiety: Landmark study highlights risk and resilience
2026-02-10
Anxiety disorders — including generalized anxiety disorder, panic disorder and phobias — affect as many as one in four people over the course of their lives. They often begin early in life and persist for years, inflicting significant personal, social and economic consequences.
Now, a major breakthrough published in Nature Genetics is offering the clearest picture yet of the genetic roots of these conditions.
In what is now the largest genome‑wide association study (GWAS) of clinically diagnosed anxiety disorders ever conducted, an international ...
How UCLA scientists helped reimagine a forgotten battery design from Thomas Edison
2026-02-10
A little-known fact: In the year 1900, electric cars outnumbered gas-powered ones on the American road.
The lead-acid auto battery of the time, courtesy of Thomas Edison, was expensive and had a range of only about 30 miles. Seeking to improve on this, Edison believed the nickel-iron battery was the future, with the promise of a 100-mile range, a long life and a recharge time of seven hours, fast for that era.
Alas, that promise never reached fruition. Early electric car batteries still suffered from serious limitations, and advances in ...
Dementia Care Aware collaborates with the Institute for Healthcare Improvement to advance age-friendly health systems
2026-02-10
SAN FRANCISCO (Feb. 10, 2026) — Dementia Care Aware (DCA) is collaborating with the Institute for Healthcare Improvement (IHI) to support its March 2026 Action Community, a community learning experience that helps health systems across the country implement the 4Ms Framework of an Age-Friendly Health System. DCA is a national organization dedicated to improving dementia detection and care by providing health care teams the education, tools and support necessary to offer high-quality dementia care. This new collaboration advances DCA’s and IHI’s shared goals ...
Growth of spreading pancreatic cancer fueled by 'under-appreciated' epigenetic changes
2026-02-10
FOR IMMEDIATE RELEASE
In a lab-grown cell study focused on potential new treatment targets for halting the spread of most pancreatic cancers, Johns Hopkins Medicine scientists report they have found that a gene called KLF5 (Krueppel-like factor 5) fuels the growth of such spreading tumors not by acquiring abnormal changes in the cancer cells’ DNA code itself but by altering chemical changes and organization of DNA, or epigenetics, that turns genes on and off.
“Epigenetic alterations are underappreciated ...
Lehigh University professor Israel E. Wachs elected to National Academy of Engineering
2026-02-10
Israel E. Wachs, the G. Whitney Snyder Distinguished Professor of Chemical and Biomolecular Engineering at Lehigh University, has been elected to the National Academy of Engineering (NAE), one of the highest professional honors in the field of engineering. Wachs was recognized “for establishing fundamental structure–activity/selectivity rules governing molecular engineering of mixed oxide catalysts” that guide the rational design of solid catalysts (materials that accelerate and control chemical reactions) for air pollution ...
Brain stimulation can nudge people to behave less selfishly
2026-02-10
Stimulating two brain areas, nudging them to collectively fire in the same way, increased a person’s ability to behave altruistically, according to a study published February 10th in the open-access journal PLOS Biology by Jie Hu from East China Normal University in China and colleagues from University of Zurich in Switzerland.
As parents raise their kids, they often work to teach them to be kind and to share, to think about other people and their needs—to be altruistic. This unselfish attitude is critical if a society is ...
Shorter treatment regimens are safe options for preventing active tuberculosis
2026-02-10
A study comparing one- and three-month antibiotic treatments to prevent active tuberculosis (TB) finds that a high percentage of patients successfully completed both regimens and suffered few adverse side effects. A team led by Richard Chaisson, of the Johns Hopkins School of Medicine, U.S.A., reports these findings February 10th in the open access journal PLOS Medicine.
After someone is exposed to TB, the World Health Organization has traditionally recommended six to nine months of antibiotic treatment to prevent an active infection from developing, but many individuals fail to complete the long course of medication. Studies have shown that ...
How food shortages reprogram the immune system’s response to infection
2026-02-10
When food is scarce, stress hormones direct the immune system to operate in “low power” mode to preserve immune function while conserving energy, according to researchers at Weill Cornell Medicine. This reconfiguration is crucial to combating infections amid food insecurity.
When food is scarce, stress hormones direct the immune system to operate in “low power” mode to preserve immune function while conserving energy, according to researchers at Weill Cornell Medicine. This reconfiguration is crucial to combating ...
The wild physics that keeps your body’s electrical system flowing smoothly
2026-02-10
AMHERST, Mass. — Building on their groundbreaking 2018 research into how some of the body’s cells, such as neurons and cardiac tissue, communicate via ions that flow through cellular channels, chemists at the University of Massachusetts Amherst demonstrated a “leakiness” to a particularly mysterious type of channel, known as a “big potassium,” or BK channel. This leakiness is key to further study the body’s electrical infrastructure, which, when it goes haywire, can result in maladies like epilepsy and hypertension.
Instead of electron-carrying wires, electricity flows through our bodies in ion-carrying cellular ...